GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xtant Medical Holdings Inc (FRA:XMS) » Definitions » Cyclically Adjusted PB Ratio

Xtant Medical Holdings (FRA:XMS) Cyclically Adjusted PB Ratio : (As of Jun. 10, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Xtant Medical Holdings Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Xtant Medical Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Xtant Medical Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xtant Medical Holdings Cyclically Adjusted PB Ratio Chart

Xtant Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.66 - - - -

Xtant Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Xtant Medical Holdings's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Xtant Medical Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Cyclically Adjusted PB Ratio falls into.



Xtant Medical Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Xtant Medical Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Xtant Medical Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.337/131.7762*131.7762
=0.337

Current CPI (Mar. 2024) = 131.7762.

Xtant Medical Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201406 -11.553 100.560 -15.139
201409 -5.648 100.428 -7.411
201412 -10.304 99.070 -13.706
201503 -14.990 99.621 -19.828
201506 -15.436 100.684 -20.203
201509 -2.316 100.392 -3.040
201512 7.475 99.792 9.871
201603 2.769 100.470 3.632
201606 -0.397 101.688 -0.514
201609 -4.066 101.861 -5.260
201612 -4.628 101.863 -5.987
201703 -7.184 102.862 -9.203
201706 -12.470 103.349 -15.900
201709 -16.616 104.136 -21.026
201712 -32.486 104.011 -41.158
201803 0.961 105.290 1.203
201806 0.665 106.317 0.824
201809 0.817 106.507 1.011
201812 -2.900 105.998 -3.605
201903 -2.615 107.251 -3.213
201906 -2.742 108.070 -3.343
201909 -2.935 108.329 -3.570
201912 -3.001 108.420 -3.647
202003 -3.158 108.902 -3.821
202006 -3.124 108.767 -3.785
202009 -3.054 109.815 -3.665
202012 0.154 109.897 0.185
202103 0.323 111.754 0.381
202106 0.324 114.631 0.372
202109 0.320 115.734 0.364
202112 0.314 117.630 0.352
202203 0.305 121.301 0.331
202206 0.305 125.017 0.321
202209 0.325 125.227 0.342
202212 0.296 125.222 0.311
202303 0.281 127.348 0.291
202306 0.262 128.729 0.268
202309 0.395 129.860 0.401
202312 0.362 129.419 0.369
202403 0.337 131.776 0.337

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Xtant Medical Holdings  (FRA:XMS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Xtant Medical Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Xtant Medical Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Xtant Medical Holdings (FRA:XMS) Business Description

Traded in Other Exchanges
Address
664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Xtant Medical Holdings (FRA:XMS) Headlines

No Headlines